Details for Patent: 10,961,240
✉ Email this page to a colleague
Which drugs does patent 10,961,240 protect, and when does it expire?
Patent 10,961,240 protects TURALIO and is included in one NDA.
This patent has twelve patent family members in nine countries.
Summary for Patent: 10,961,240
Title: | Formulations of a compound modulating kinases |
Abstract: | Provided are compositions comprising Compound I having the following structure: ##STR00001## or a pharmaceutically acceptable salt thereof, and a solubilizing agent; methods of making the same; and methods of using the same. |
Inventor(s): | Ibrahim; Prabha N. (Mountain View, CA), Rezaei; Hamid (Berkeley, CA), Visor; Gary Conard (Castro Valley, CA), Kamo; Tomoari (Tokyo, JP), Yamakose; Hiroshi (Tokyo, JP) |
Assignee: | Plexxikon Inc. (Berkeley, CA) Daiichi Sankyo Company, Limited (Tokyo, JP) |
Application Number: | 16/510,757 |
Patent Claim Types: see list of patent claims | Use; Composition; Device; Dosage form; |
Drugs Protected by US Patent 10,961,240
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daiichi Sankyo Inc | TURALIO | pexidartinib hydrochloride | CAPSULE;ORAL | 211810-002 | Oct 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF ADULT PATIENTS WITH SYMPTOMATIC TENOSYNOVIAL GIANT CELL TUMOR (TGCT) ASSOCIATED WITH SEVERE MORBIDITY OR FUNCTIONAL LIMITATIONS AND NOT AMENABLE TO IMPROVEMENT WITH SURGERY | ⤷ Sign Up | ||||
Daiichi Sankyo Inc | TURALIO | pexidartinib hydrochloride | CAPSULE;ORAL | 211810-001 | Aug 2, 2019 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF ADULT PATIENTS WITH SYMPTOMATIC TENOSYNOVIAL GIANT CELL TUMOR (TGCT) ASSOCIATED WITH SEVERE MORBIDITY OR FUNCTIONAL LIMITATIONS AND NOT AMENABLE TO IMPROVEMENT WITH SURGERY | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,961,240
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2018307910 | ⤷ Sign Up | |||
Brazil | 112019028235 | ⤷ Sign Up | |||
Canada | 3070505 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |